remede System
Device Respiratory
General payments
$2,363,704
Research payments
$1,992,439
Through program year 2025, $2,363,704 in general payments and $1,992,439 in research payments were reported against remede System (Respiratory).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
14 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $301,149 | 1,406 |
| 2025 | Research | $458,283 | 161 |
| 2024 | General | $325,926 | 1,543 |
| 2024 | Research | $392,419 | 132 |
| 2023 | General | $343,032 | 1,567 |
| 2023 | Research | $289,067 | 115 |
| 2022 | General | $380,963 | 252 |
| 2022 | Research | $184,285 | 73 |
| 2021 | General | $320,065 | 401 |
| 2021 | Research | $215,826 | 24 |
| 2020 | General | $319,358 | 123 |
| 2020 | Research | $235,143 | 32 |
| 2019 | General | $373,211 | 300 |
| 2019 | Research | $217,415 | 25 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 48 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,592 general · 562 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.